Company / Revenue per Share
Insulet Corporation Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$38.58
FY2025
5-year range
$16.64 / $38.58
FY2021-FY2025
Trend
+30.2%
vs FY2024
Sector context
#50 of 147
Health Care
What the data says
At $38.58, Insulet Corporation's revenue per share ranks #50 of 147 in the Health Care sector. Revenue per Share has increased for 9 consecutive years, from $6.44 in FY2016 to $38.58 in FY2025.
Based on SEC 10-K filings.
38.58 in FY2025 with a 5-year CAGR of +21.7%.
Improved from $24.41 to $38.58 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +26.9%
- 5-Year CAGR
- +21.7%
- 10-Year CAGR
- -
Sector benchmark
#50 of 147 in Health CareTop 34% of 147This company $38.58 Sector average $127.83
▼
-69.8% below sector average
Key checks
Key Insights
- Insulet Corporation's revenue per share has grown for 9 consecutive years.
- In FY2025, revenue per share increased 30.2% year-over-year.
- Ranks #50 out of 147 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $38.58 | +30.2% |
| FY2024 | $29.63 | +21.4% |
| FY2023 | $24.41 | +29.4% |
| FY2022 | $18.87 | +13.4% |
| FY2021 | $16.64 | +15.4% |
| FY2020 | $14.43 | +15.7% |
| FY2019 | $12.47 | +29.0% |
| FY2018 | $9.67 | +19.8% |
| FY2017 | $8.07 | +25.3% |
| FY2016 | $6.44 | +37.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026